Govt panel recommends EUA for Biological Es Corbevax for 5 to 11 years
New Delhi Apr 21 PTI An expert panel of Indias central drug authority has recommended granting emergency use authorisation for Biological Es COVID-19 vaccine Corbevax for children in the five to 11 years age group official sources said on ThursdayThe Subject Expert Committee on COVID-19 of the CDSCO has however sought more data from Bharat Biotech to review its emergency use authorisation EUA application for use of Covaxin among those aged between two and 11 years they saidThe Drugs Controller General of India DCGI had approved Covovax for restricted use in emergency situations in adults on December 28 last year and in the 12 to 17 years age group subject to certain conditions on March 9 this yearBiological Es Corbevax is being used to inoculate children against COVID-19 in the age group of 12 to 14 years Covaxin has been granted Emergency Use Listing EUL by the DCGI for the age group of 12to 18 years on December 24 2021The Subject Expert Committee on COVID-19 of the CDSCO which deliberated on Biological EsEUA application has recommended granting emergency use authorisation for use of Corbevax in the age group of five to 11 years a source saidIndia began inoculating children aged 12-14 on March 16 The countrywide vaccination drive was rolled out on January 16 last year with healthcare workers getting inoculated in the first phase Vaccination of frontline workers started from February 2 last yearThe next phase of COVID-19 vaccination commenced on March 1 last year for people over 60 years of age and those aged 45 and above with specified co-morbid conditionsIndia launched vaccination for all people aged more than 45 years from April 1 last year The government then decided to expand its vaccination drive by allowing everyone above 18 years of age to be inoculated against the viral disease from May 1 last yearThe next phase of vaccination commenced on January 3 for adolescents in the age group of 15-18 yearsIndia began administering precaution doses of vaccines to healthcare and frontline workers and those aged 60 and above with comorbidities from January 10 Precaution does of COVID-19 vaccines to all aged above 18 years was allowed at private vaccination centres from April 10 PTI PLB NSD NSD
New Delhi Apr 21 PTI An expert panel of Indias central drug authority has recommended granting emergency use authorisation for Biological Es COVID-19 vaccine Corbevax for children in the five to 11 years age group official sources said on ThursdayThe Subject Expert Committee on COVID-19 of the CDSCO has however sought more data from Bharat Biotech to review its emergency use authorisation EUA application for use of Covaxin among those aged between two and 11 years they saidThe Drugs Controller General of India DCGI had approved Covovax for restricted use in emergency situations in adults on December 28 last year and in the 12 to 17 years age group subject to certain conditions on March 9 this yearBiological Es Corbevax is being used to inoculate children against COVID-19 in the age group of 12 to 14 years Covaxin has been granted Emergency Use Listing EUL by the DCGI for the age group of 12to 18 years on December 24 2021The Subject Expert Committee on COVID-19 of the CDSCO which deliberated on Biological EsEUA application has recommended granting emergency use authorisation for use of Corbevax in the age group of five to 11 years a source saidIndia began inoculating children aged 12-14 on March 16 The countrywide vaccination drive was rolled out on January 16 last year with healthcare workers getting inoculated in the first phase Vaccination of frontline workers started from February 2 last yearThe next phase of COVID-19 vaccination commenced on March 1 last year for people over 60 years of age and those aged 45 and above with specified co-morbid conditionsIndia launched vaccination for all people aged more than 45 years from April 1 last year The government then decided to expand its vaccination drive by allowing everyone above 18 years of age to be inoculated against the viral disease from May 1 last yearThe next phase of vaccination commenced on January 3 for adolescents in the age group of 15-18 yearsIndia began administering precaution doses of vaccines to healthcare and frontline workers and those aged 60 and above with comorbidities from January 10 Precaution does of COVID-19 vaccines to all aged above 18 years was allowed at private vaccination centres from April 10 PTI PLB NSD NSD
